drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate)
August 2003
Some drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate).
It's true that some comparisons show a potential advantage to Actonel. But there are also studies showing no difference.
Most of the research is company-sponsored. It's no surprise that results tend to favor the sponsoring company's drug.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote